Cargando…
Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After chromosome abnormality, thrombophilia is one of the most important genetic factors that could cause RPL. Factor V Leiden and factor II G20210A mutation were the most common mutations cause thrombophil...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Clinical Center for Infertility
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941375/ https://www.ncbi.nlm.nih.gov/pubmed/24639694 |
_version_ | 1782305907129974784 |
---|---|
author | Teremmahi Ardestani, Majid Nodushan, Hossein Hadi Aflatoonian, Abbas Ghasemi, Nasrin Sheikhha, Mohammad Hasan |
author_facet | Teremmahi Ardestani, Majid Nodushan, Hossein Hadi Aflatoonian, Abbas Ghasemi, Nasrin Sheikhha, Mohammad Hasan |
author_sort | Teremmahi Ardestani, Majid |
collection | PubMed |
description | Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After chromosome abnormality, thrombophilia is one of the most important genetic factors that could cause RPL. Factor V Leiden and factor II G20210A mutation were the most common mutations cause thrombophilia in the world. Objective: The purpose of this study was to determine the frequency of factor V Leiden and prothrombine gene mutations in women with RPL compared with women who had uneventful pregnancies. Materials and Methods: This case control study evaluates the frequency of factor V-Leiden and factor II G20210 genotypes in 80 women with two or more pregnancy losses, compared with 80 women without adverse pregnancy outcome. The mutations were assessed by PCR-RFLP. Results: Frequency of the factor V Leiden among cases was 2.5%, which was higher than controls (1.25%), but the difference was not significant. No factor II G20210 mutation was found among cases and controls. Conclusion: These data did not confirm that factor V Leiden and factor II G20210 mutation might play a role in recurrent pregnancy loss in Iranian women. |
format | Online Article Text |
id | pubmed-3941375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Research and Clinical Center for Infertility |
record_format | MEDLINE/PubMed |
spelling | pubmed-39413752014-03-17 Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss Teremmahi Ardestani, Majid Nodushan, Hossein Hadi Aflatoonian, Abbas Ghasemi, Nasrin Sheikhha, Mohammad Hasan Iran J Reprod Med Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After chromosome abnormality, thrombophilia is one of the most important genetic factors that could cause RPL. Factor V Leiden and factor II G20210A mutation were the most common mutations cause thrombophilia in the world. Objective: The purpose of this study was to determine the frequency of factor V Leiden and prothrombine gene mutations in women with RPL compared with women who had uneventful pregnancies. Materials and Methods: This case control study evaluates the frequency of factor V-Leiden and factor II G20210 genotypes in 80 women with two or more pregnancy losses, compared with 80 women without adverse pregnancy outcome. The mutations were assessed by PCR-RFLP. Results: Frequency of the factor V Leiden among cases was 2.5%, which was higher than controls (1.25%), but the difference was not significant. No factor II G20210 mutation was found among cases and controls. Conclusion: These data did not confirm that factor V Leiden and factor II G20210 mutation might play a role in recurrent pregnancy loss in Iranian women. Research and Clinical Center for Infertility 2013-01 /pmc/articles/PMC3941375/ /pubmed/24639694 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Teremmahi Ardestani, Majid Nodushan, Hossein Hadi Aflatoonian, Abbas Ghasemi, Nasrin Sheikhha, Mohammad Hasan Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss |
title | Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss |
title_full | Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss |
title_fullStr | Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss |
title_full_unstemmed | Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss |
title_short | Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss |
title_sort | case control study of the factor v leiden and factor ii g20210a mutation frequency in women with recurrent pregnancy loss |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941375/ https://www.ncbi.nlm.nih.gov/pubmed/24639694 |
work_keys_str_mv | AT teremmahiardestanimajid casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss AT nodushanhosseinhadi casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss AT aflatoonianabbas casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss AT ghaseminasrin casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss AT sheikhhamohammadhasan casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss |